About ibandronic acid
Bisphosphonate bone resorption inhibitor
Used for
- Treats osteoporosis in postmenopausal women and reduces fracture risk.
Usual adult dose
3 mg by intravenous injection every 3 months.
Common side effects
- Flu-like symptoms, muscle or joint pain, headache, and fatigue.
- Low blood calcium.
- Injection-site reactions.
Important warnings
- Correct low calcium and vitamin D deficiency before treatment.
- Kidney function should be checked; avoid use in severe kidney impairment.
- Rarely, jawbone problems or unusual thigh fractures occur.
- Do not administer into an artery or surrounding tissue.
Pregnancy
Not recommended during pregnancy; there is limited human safety information.
Breastfeeding
Breastfeeding is not recommended during treatment; whether the medicine enters breast milk is uncertain.
Interactions
- Other medicines affecting the kidneys may increase kidney-related risks.
- Calcium supplements and antacids can affect calcium levels; separate oral products from oral ibandronate, though this injection is unaffected.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.